The Chief Experience Officer – An Emerging & Critical Role

This paper explores the impact and influence of the growing role of Chief Experience Officer (CXO) . It is a role that encompasses and leads a broad portfolio of resources and services fundamental to the patient and family experience – from advocacy to service and, in some cases, broadening to lead or significantly influence people, quality and safety issues. The paper asserts that if an organization wishes to lead in the patient and family experience, the role of CXO or Senior Patient Experience Leader must be part of an organization’s senior leadership and is central to a broader commitment on patient experience excellence.
Related content
-
Culture & Leadership | Infrastructure & Governance | Innovation & Technology
ED Processes & Improvements: Implementation Best Practices & Outcomes
In this webinar, an Associate Chief Experience Officer, a Program Director, an Analyst, and a consultant will present what they did to improve patient experience outcomes across seven hospitals’ emergency departments which resulted in improved HCAHPS scores in all seven hospitals. The strategic, systemwide process improvements are based on analyses provided through Epic tools and
Learn more -
Culture & Leadership | Staff & Provider Engagement
Shaping a Human-Centered Patient Experience Across Interdisciplinary Teams
Patient experience directly impacts patient wellbeing and care outcomes, as well as the reputation of the hospital. But is the patient experience defined by the medical care alone? A recent deep-dive study on Voice of the Patient Data highlights the fact that 53% of patients’ feedback focuses on the medical care and teams. The study
Learn more -
Culture & Leadership
Contrasting Patients’ and Healthcare Professionals’ Experience in Hematological Cancer Care Pathway : A Narrative Study
Hematological cancers represent 10% of cancers diagnosed in Canada. Treatments involve complex care pathways and various modalities as well as the management and monitoring of multiple side effects. There is limited understanding of these pathways from the perspectives of the people living with cancer (PLC) and the healthcare professional (HCP). The aim of this article
Learn more